AGE/RAGE signalling regulation by miRNAs: Associations with diabetic complications and therapeutic potential

International Journal of Biochemistry and Cell Biology

Volumn 60, Issue , 2015, Pages 197-201

  Piperi, Christina ^a   Goumenos, Athanasios ^a   Adamopoulos, Christos ^a   Papavassiliou, Athanasios G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

AGE RAGE signalling; Diabetes; MiRNAs; Therapy

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; REACTIVE OXYGEN METABOLITE;

ARTICLE; DIABETES MELLITUS; ENDOPLASMIC RETICULUM STRESS; GENE CONTROL; GENE EXPRESSION; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; RESPIRATORY CHAIN; SIGNAL TRANSDUCTION; ANIMAL; GENETICS; METABOLISM;

ANIMALS; DIABETES MELLITUS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MICRORNAS; NF-KAPPA B; REACTIVE OXYGEN SPECIES;

EID: 84921737670     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2015.01.009     Document Type: Short Survey

References (36)

1. S. Bansal, D. Chawla, M. Siddarth, B.D. Banerjee, S.V. Madhu, and A.K. Tripathi A study on serum advanced glycation end products and its association with oxidative stress and paraoxonase activity in type 2 diabetic patients with vascular complications Clin Biochem 46 2013 109 114
2. M. Busch, S. Franke, C. Rüster, and G. Wolf Advanced glycation end-products and the kidney Eur J Clin Invest 40 2010 742 755
3. A. Caporali, M. Meloni, C. Völlenkle, D. Bonci, G.B. Sala-Newby, and R. Addis Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia Circulation 123 2011 282 291
4. N.C. Chilelli, S. Burlina, and A. Lapolla AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view Nutr Metab Cardiovasc Dis 23 2013 913 919
5. S.J. Cho, G. Roman, F. Yeboah, and Y. Konishi The road to advanced glycation end products: a mechanistic perspective Curr Med Chem 14 2007 1653 1671
6. A.C. Chung, Y. Dong, W. Yang, X. Zhong, R. Li, and H.Y. Lan Smad7 suppresses renal fibrosis via altering expression of TGF-β/Smad3-regulated microRNAs Mol Ther 21 2013 388 398
7. M.T. Coughlan, D.R. Thorburn, S.A. Penfold, A. Laskowski, B.E. Harcourt, and K.C. Sourris RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes J Am Soc Nephrol 20 2009 742 752
8. S.M. Eken, H. Jin, E. Chernogubova, and L. Maegdefessel Making sense in antisense: therapeutic potential of noncoding RNAs in diabetes-induced vascular dysfunction J Diabetes Res 2013 2013 834727
9. L. Fiorentino, M. Cavalera, M. Mavilio, F. Conserva, R. Menghini, and L. Gesualdo Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs Acta Diabetol 50 2013 965 969
10. F. Fleissner, V. Jazbutyte, J. Fiedler, S.K. Gupta, X. Yin, and Q. Xu Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism Circ Res 107 2010 138 143
11. I.J. Gallagher, C. Scheele, P. Keller, A.R. Nielsen, J. Remenyi, and C.P. Fischer Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes Genome Med 2 2010 9
12. S. Hagiwara, A. McClelland, and P. Kantharidis MicroRNA in diabetic nephropathy: renin angiotensin, aGE/RAGE, and oxidative stress pathway J Diabetes Res 2013 2013 173783
13. O. Hofnagel, B. Luechtenborg, G. Weissen-Plenz, and H. Robenek Statins and foam cell formation: impact on LDL oxidation and uptake of oxidized lipoproteins via scavenger receptors Biochim Biophys Acta 1771 2007 1117 1124
14. M. Kato, N.E. Castro, and R. Natarajan MicroRNAs: potential mediators and biomarkers of diabetic complications Free Radical Biol Med 65 2013 85 94
15. H.Y. Lan Transforming growth factor-β/Smad signalling in diabetic nephropathy Clin Exp Pharmacol Physiol 39 2012 731 738
16. L.M. Li, D.X. Hou, Y.L. Guo, J.W. Yang, Y. Liu, and C.Y. Zhang Role of microRNA-214-targeting phosphatase and tensin homolog in advanced glycation end product-induced apoptosis delay in monocytes J Immunol 186 2011 2552 2560
17. F. Liu, Y.L. Lou, J. Wu, Q.F. Ruan, A. Xie, and F. Guo Upregulation of microRNA-210 regulates renal angiogenesis mediated by activation of VEGF signaling pathway under ischemia/perfusion injury in vivo and in vitro Kidney Blood Press Res 35 2012 182 191
18. M. McNulty, A. Mahmud, and J. Feely Advanced glycation end-products and arterial stiffness in hypertension Am J Hypertens 20 2007 242 247
19. S. Muratsu-Ikeda, M. Nangaku, Y. Ikeda, T. Tanaka, T. Wada, and R. Inagi Downregulation of miR-205 modulates cell susceptibility to oxidative and endoplasmic reticulum stresses in renal tubular cells PLoS ONE 7 2012 e41462
20. O. Nedić, S.I. Rattan, T. Grune, and I.P. Trougakos Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology Free Radical Res 47 2013 28 38
21. Y. Pan, H. Liang, H. Liu, D. Li, X. Chen, and L. Li Platelet-secreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor J Immunol 192 2014 437 446
22. G. Pasterkamp Methods of accelerated atherosclerosis in diabetic patients Heart 99 2013 743 749
23. C. Piperi, C. Adamopoulos, G. Dalagiorgou, E. Diamanti-Kandarakis, and A.G. Papavassiliou Crosstalk between advanced glycation and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseases J Clin Endocrinol Metab 97 2012 2231 2242
24. R. Ramasamy, S.F. Yan, and A.M. Schmidt Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications Ann NY Acad Sci 1243 2011 88 102
25. N. Shanmugam, M. Redy, and R. Natarajan Distinct roles of heterogeneous nuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100b, a ligand of the receptor for advanced glycation end products J Biol Chem 283 2008 36221 36233
26. S. Shi, L. Yu, C. Chiu, Y. Sun, J. Chen, and G. Khitrov Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis J Am Soc Nephrol 19 2008 2159 2169
27. L.J. Sparvero, D. Asafu-Adjei, R. Kang, D. Tang, N. Amin, and J. Im RAGE (Receptor for Advanced Glycation Endproducts). RAGE ligands, and their role in cancer and inflammation J Transl Med 7 2009 17
28. A.W. Stitt AGEs and diabetic retinopathy Invest Ophthalmol Vis Sci 51 2010 4867 4874
29. M. Takeuchi, and S. Yamagishi Involvement of toxic AGEs (TAGE) in the pathogenesis of diabetic vascular complications and Alzheimer's disease J Alzheimers Dis 16 2009 845 858
30. G. Togliatto, A. Trombetta, P. Dentelli, A. Rosso, and M.F. Brizzi MIR221/MIR222-driven post-transcriptional regulation of P27KIP1 and P57KIP2 is crucial for high-glucose- and AGE-mediated vascular cell damage Diabetologia 54 2011 1930 1940
31. X.D. Wu, W.L. Liu, K. Zeng, H.Y. Lei, Q.G. Zhang, and S.Q. Zhou Advanced glycation end products activate the miRNA/RhoA/ROCK2 pathway in endothelial cells Microcirculation 21 2014 178 186
32. Y. Xiang, Q. Li, M. Li, W. Wang, C. Cui, and J. Zhang Ghrelin inhibits AGEs-induced apoptosis in human endothelial cells involving ERK1/2 and PI3K/Akt pathways Cell Biochem Funct 29 2011 149 155
33. S. Yamagishi Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes Exp Gerontol 46 2011 217 224
34. A. Zampetaki, S. Kiechl, I. Drozdov, P. Willeit, U. Mayr, and M. Prokopi Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes Circ Res 107 2010 810 817
35. N. Zhu, D. Zhang, S. Chen, X. Liu, L. Lin, and X. Huang Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration Atherosclerosis 215 2011 286 293
36. T. Zitman-Gal, J. Green, M. Pasmanik-Chor, E. Golan, J. Bernheim, and S. Benchetrit Vitamin D manipulates miR-181c, miR-20b and miR-15a in human umbilical vein endothelial cells exposed to a diabetic-like environment Cardiovasc Diabetol 13 2014 8